US FDA v. COVID Mutants: Multi-Factorial Assessments Will Determine When Product EUAs Need To Change

 
• By Sarah Karlin-Smith
COVID gears (shutterstock)
FDA is conducting wide-ranging scenario planning to deal with virus changes • Source: Shutterstock

More from Vaccines

More from Pink Sheet